how do glp-1 receptor agonists work For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Frontiers | GLP−1 receptor agonists

Dulaglutide , taken weekly: FDAapproved to improve A1C levels in patients with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors under the brand name Trulicity

Outstanding questions As GLP-1 RAs continue to expand beyond their original indications, several important questions remain

Home et al., 2009

In this study, the potential effects of GLP-1RAs on the occurrence and development of tumors were reviewed to provide new ideas for the prevention and treatment of tumors in patients

A physiological DPP-4 substrate is defined as one whose relative levels of intact versus cleaved peptide are significantly different in an animal or human treated with a DPP-4 inhibitor, or in an animal with genetic inactivation of DPP-4 (e.g., GIP, GLP-1, GLP-2, Peptide tyrosine tyrosine [PYY], Stromal cell-derived factor-1 [SDF], and Substance P [SP])

The most frequently reported side effects were gastrointestinal side effects of mild-moderate intensity and were transient over time